Total Medical devices industry cross border deals worth $3.1bn were announced globally for June 2022, with the $1bn acquisition of MediFox DAN Group being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 305.4% over the previous month of $774.46m and a drop of 15.8% when compared with the last 12-month average of $3.73bn.
In terms of number of cross border deals, the sector saw a rise of 1.69% with 60 deals in June 2022 when compared to the last 12-month average of 59 deals.
In value terms, Europe led the activity with cross border deals worth $2.13bn in June 2022.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataMedical devices industry cross border deals in June 2022: Top deals
The top five cross border deals accounted for 73.7% of the overall value during June 2022.
The combined value of the top five cross border deals stood at $2.32bn, against the overall value of $3.1bn recorded for the month.
The top five Medical devices industry cross border deals of June 2022 tracked by GlobalData were:
1) ResMed $1bn acquisition deal with MediFox DAN Group
2) The $797.86m private equity of SPT Labtech by EQT IX Fund
3) Boston Scientific $230m acquisition deal for 64% stake in M.I.Tech
4) The $177.8m acquisition of Guardant Health AMEA by Guardant Health
5) Alpha Intelligence Capital,CDIB Capital and TCMI $110m venture financing deal with Aidoc Medical
